Cargando…

Symptoms and experiences of frailty in lung cancer patients with chemotherapy: A mixed-method approach

OBJECTIVE: The aim of this study was to explore the symptoms and experiences of frailty in lung cancer patients treated with chemotherapy. METHODS: Quantitative and qualitative research methods were implemented. A total of 302 patients aged > 18 years were recruited by convenience sampling method...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duan, Liran, Cui, Huixia, Zhang, Wenlu, Wu, Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582838/ https://www.ncbi.nlm.nih.gov/pubmed/36276107 http://dx.doi.org/10.3389/fonc.2022.1019006

Ejemplares similares

Oral Chemotherapy for Treatment of Lung Cancer
por: Jonna, Sushma, et al.
Publicado: (2020)

Development and validation of a chemotherapy tolerance prediction model for Chinese multiple myeloma patients: The TM frailty score
por: Chen, Yadong, et al.
Publicado: (2023)

Sexual Function, Quality of Life, and Experiences of Women with Ovarian Cancer: A Mixed-Methods Study
por: Fischer, Olivia J., et al.
Publicado: (2019)

Predicting muscle loss during lung cancer treatment (PREDICT): protocol for a mixed methods prospective study
por: Kiss, Nicole K, et al.
Publicado: (2021)

Implementation of a lung cancer multidisciplinary team standardised template for reporting to general practitioners: a mixed-method study
por: Rankin, Nicole M, et al.
Publicado: (2017)

Traumatic stress symptoms in family caregivers of patients with acute leukaemia: protocol for a multisite mixed methods, longitudinal, observational study
por: Jibb, Lindsay A, et al.
Publicado: (2022)

Lung Cancer in Pregnancy: An Unusual Case of Complete Response to Chemotherapy
por: Yates, Ryan, et al.
Publicado: (2015)

Differences in experiences of care between patients diagnosed with metastatic cancer of known and unknown primaries: mixed-method findings from the 2013 cancer patient experience survey in England
por: Wagland, Richard, et al.
Publicado: (2017)

Cost-effectiveness of cemiplimab plus chemotherapy versus chemotherapy for the treatment of advanced non-small cell lung cancer
por: Liang, Xueyan, et al.
Publicado: (2023)

Neoadjuvant camrelizumab and chemotherapy in patients with resectable stage IIIA squamous non-small-cell lung cancer: Clinical experience of three cases
por: Li, Xin, et al.
Publicado: (2022)

Adjuvant Chemotherapy for Early Stage Non-Small Cell Lung Cancer
por: Patel, Manali I., et al.
Publicado: (2011)

Symptoms and Experiences with Small Cell Lung Cancer: A Mixed Methods Study of Patients and Caregivers
por: Bebb, D. Gwyn, et al.
Publicado: (2023)

Immune checkpoint inhibitors alone or in combination with chemotherapy for treatment of advanced non-small cell lung cancer after first-line platinum-based chemotherapy: A propensity score matching analysis
por: Qiu, Lupeng, et al.
Publicado: (2022)

Measurement of Sarcopenia in Head and Neck Cancer Patients and Its Association With Frailty
por: de Bree, Remco, et al.
Publicado: (2022)

Cost-Effectiveness of Nivolumab Plus Ipilimumab With and Without Chemotherapy for Advanced Non-Small Cell Lung Cancer
por: Yang, Szu-Chun, et al.
Publicado: (2021)

Changes and Influencing Factors of Cognitive Impairment in Patients with Breast Cancer
por: Cui, Huixia, et al.
Publicado: (2021)

Development of Approaches and Metrics to Measure the Impact and Improve the Clinical Outcomes of Patients With Frailty in the Era of COVID-19. The COMETA Italian Protocol
por: Silvestris, Nicola, et al.
Publicado: (2022)

Neoadjuvant immunotherapy combined with chemotherapy significantly improved patients’ overall survival when compared with neoadjuvant chemotherapy in non-small cell lung cancer: A cohort study
por: Dai, Fuqiang, et al.
Publicado: (2022)

Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab vs. Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
por: Hu, Huabin, et al.
Publicado: (2020)

A Decision-Making Supporting Prediction Method for Breast Cancer Neoadjuvant Chemotherapy
por: Song, Dong, et al.
Publicado: (2021)

Frailty and long-term survival of patients with gastric cancer: a meta-analysis
por: Liang, Hongliang, et al.
Publicado: (2023)

Frailty and medical financial hardship among older adults with cancer in the United States
por: Lao, Jiahui, et al.
Publicado: (2023)

Feasibility of Prehabilitation Prior to Breast Cancer Surgery: A Mixed-Methods Study
por: Brahmbhatt, Priya, et al.
Publicado: (2020)

Advances in Imaging in Evaluating the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
por: Kong, Xianshu, et al.
Publicado: (2022)

Distinct Subgroups of Patients With Lung Cancer Receiving Chemotherapy: A Latent Transition Analysis
por: Li, Nannan, et al.
Publicado: (2020)

Nestin Expression Affects Resistance to Chemotherapy and Clinical Outcome in Small Cell Lung Cancer
por: Sone, Kazuki, et al.
Publicado: (2020)

Role of Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer in the COVID-19 Pandemic
por: Karaman, Elanur, et al.
Publicado: (2022)

One Cycle of Concurrent Chemotherapy vs. Two Cycles of Concurrent Chemotherapy With Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer
por: Yu, Hao, et al.
Publicado: (2022)

Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
por: Wu, Gujie, et al.
Publicado: (2023)

International Survey on Frailty Assessment in Patients with Cancer
por: Banna, Giuseppe Luigi, et al.
Publicado: (2022)

A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts ALK Rearrangement Status in Lung Adenocarcinoma
por: Chang, Cheng, et al.
Publicado: (2021)

Identification of Immune-Related Breast Cancer Chemotherapy Resistance Genes via Bioinformatics Approaches
por: Du, Yabing, et al.
Publicado: (2022)

Risk factors for acute exacerbation of interstitial lung disease during chemotherapy for lung cancer: a systematic review and meta-analysis
por: Wang, Zhen, et al.
Publicado: (2023)

Frailty affects prognosis in patients with colorectal cancer: A systematic review and meta-analysis
por: Cai, Minghao, et al.
Publicado: (2022)

Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for the Prediction of Neoadjuvant Chemotherapy-Insensitive Breast Cancers
por: Wang, Zhongyi, et al.
Publicado: (2021)

Readiness for cancer rehabilitation in Denmark: protocol for a cross-sectional mixed methods study
por: Kristiansen, Maria, et al.
Publicado: (2013)

Electronic symptom monitoring in patients with metastatic lung cancer: a feasibility study
por: Friis, Rasmus Blechingberg, et al.
Publicado: (2020)

IL-23R is Epigenetically Regulated and Modulated by Chemotherapy in Non-Small Cell Lung Cancer
por: Baird, Anne-Marie, et al.
Publicado: (2013)

Case Report: Benefits of a NSCLC Patient With EGFR A289G/F287_G288insHA cis Mutations From Immunotherapy in Combination With Antiangiogenesis and Chemotherapy and Sequential Treatment of EGFR-TKI
por: Zhang, He, et al.
Publicado: (2022)

Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma
por: Guo, Long-Hua, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h2d61tkchodlu7la4bp353cqmm